Latest filing published 28 Dec 2020 for CytoDyn Inc., €110k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -7.1%Entry US$0.70 · Close at T+365 US$0.65
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael D. Mulholland: trading record in brief
Michael D. Mulholland has filed trades across 3 companies (mainly through SEC (Form 4)), most often in CytoDyn Inc., Barrett Business Services Inc and Nautilus, Inc. We count 46 filings; the first trade dates from 2 May 2006 and the latest from 22 December 2020.
Market trades split into 6 purchases (€31k) and 11 sales (€13.9M). Taken together, the sales exceed the purchases by €13.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 8 share grants and 20 option exercises. So far in 2020, the count stands at no purchases and 9 sales.
Half of the purchases are above €5,962 and half below.
On 28 December 2020 came the latest disclosure, an option exercise for €267k in CytoDyn Inc. The most recent open-market purchase was published on 17 October 2016, 3,675 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael D. Mulholland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares@ US$0.903.4% of flowCommon StockSEC:0001807094-20-000031:1
- 300,000 shares@ US$1.098.2% of flowCommon StockSEC:0001807094-20-000031:2
- 100,000 shares@ US$1.403.5% of flowCommon StockSEC:0001807094-20-000031:3
- 161,801 shares@ US$0.873.5% of flowCommon StockSEC:0001807094-20-000031:0
- 245,704 shares@ US$5.4938Common StockSEC:0001807094-20-000031:4
- 453,997 shares@ US$6.6146Common StockSEC:0001807094-20-000031:5
- 12,100 shares@ US$7.00Common StockSEC:0001807094-20-000031:6
- 589,797 shares@ US$5.582Common StockSEC:0001807094-20-000029:9
- 32,000 shares@ US$0.390.3% of flowCommon StockSEC:0001807094-20-000029:0
- 32,000 shares@ US$4.55233.7% of flowCommon StockSEC:0001807094-20-000029:1
- 155,500 shares@ US$0.391.5% of flowCommon StockSEC:0001807094-20-000029:2
- 233,100 shares@ US$0.492.9% of flowCommon StockSEC:0001807094-20-000029:3
- 98,402 shares@ US$0.571.4% of flowCommon StockSEC:0001807094-20-000029:4
- 487,002 shares@ US$4.951660.6% of flowCommon StockSEC:0001807094-20-000029:5
- 201,598 shares@ US$0.572.9% of flowCommon StockSEC:0001807094-20-000029:6
- 300,000 shares@ US$0.806.1% of flowCommon StockSEC:0001807094-20-000029:7
- 88,199 shares@ US$0.871.9% of flowCommon StockSEC:0001807094-20-000029:8
- 585,797 shares@ US$5.582Common StockSEC:0001807094-20-000030:9
- 100,000 sharesCommon StockSEC:0001807094-20-000019:0
- 153,897 shares0Common StockSEC:0000899243-19-030131:0
- 56,942 shares@ US$0.641.0% of flowCommon StockSEC:0000899243-19-030131:1
- 87,126 sharesCommon StockSEC:0000899243-18-029258:0
- 87,126 sharesCommon StockSEC:0000899243-18-029190:0
- 88,816 shares0Common StockSEC:0000899243-18-008069:0
- 38,733 shares@ US$0.690.7% of flowCommon StockSEC:0000899243-18-008069:1
25 of 37 declarations
